This episode delves into the groundbreaking technique of base editing and its potential in lowering LDL cholesterol and combating cardiovascular disease. Dr. Gonshor highlights a recent presentation at the American Heart Association, which showcased the use of CRISPR technology to target and modify genetic code within the body. The discussion includes how this innovative approach works, its clinical implications, and the promise it holds for future treatments. The episode also revisits the topic of angiogenesis inhibition in cancer therapy, adding depth to the conversation on modern medical advancements.

Join the FDN team 100+ other FDNs, and 1500+ other health-minded practitioners at the BiohackerExpo in Miami, Florida. The dates of the event are Friday, February 28th and Saturday March 1st, 2025. Go to biohackerexpo.com and use code "HDP" at checkout for 50% off tickets!